Perawatan Kanker kolon di Israel — dapatkan 3 kecocokan klinik pribadi

Dr. Pelles Sharon menempuh pelatihan di Royal Marsden – pusat kanker terkemuka di Eropa – dengan spesialisasi pada kanker gastrointestinal. Beliau mengepalai Institut Tumor Sistem Pencernaan di Ichilov.

• Menjadi ahli dalam HIPEC dan terapi target kanker kolorektal
• Mengajar di Fakultas Kedokteran Universitas Tel Aviv
• Menjadi peneliti yang memublikasikan studi tentang pengobatan adenokarsinoma pankreas
• Menjadi anggota Asosiasi Onkologi dan Radiologi Israel

Prof. Ofer Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – salah satu rumah sakit kanker terkemuka di Israel.

• Spesialisasi selama 30+ tahun dalam kasus sarkoma dan tumor kompleks
• Menjalani pelatihan fellowship di Institut Gustave Roussy, pusat kanker terkemuka di Eropa
• Anggota fakultas ESMO untuk protokol pengobatan sarkoma
• Menerbitkan penelitian luas tentang terapi kanker inovatif

Prof. Nadir Arber memimpin salah satu dari sedikit Pusat Pencegahan Kanker khusus di Israel, yang berfokus secara eksklusif pada penghentian kanker sebelum dimulai.

• Pengalaman lebih dari 30 tahun dalam menangani tumor saluran pencernaan
• Penulis lebih dari 300 karya ilmiah tentang pencegahan kanker dan terapi gen
• Kepala Pusat Pencegahan Kanker Terpadu di Tel Aviv Sourasky Medical Center
• Menjadi anggota asosiasi onkologi dan gastroenterologi internasional utama
• Menyelesaikan pekerjaan penelitian di NewYork-Presbyterian Center yang bergengsi

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.